Plain-English translation of NCT06125236 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study that will follow 8,000 patients in Southwest China who have experienced an acute ischemic stroke caused by a blockage in a large or medium-sized blood vessel in the brain. Researchers will collect information about how each patient is treated—whether with medications, procedures, or other approaches—and track their outcomes over 22 years. The goal is to build a detailed picture of how stroke care works in real-world settings and what treatments lead to the best results.
Strokes caused by large or medium blood vessel blockages are serious and life-threatening. By collecting detailed information from a large group of patients over many years, researchers hope to learn which treatments work best, identify gaps in care, and ultimately improve how doctors treat this type of stroke.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect and review your medical information—including details about your stroke, the treatments you receive, and your health outcomes—over a period of 22 years. This is an observational study, meaning you will receive standard medical care from your doctors, and researchers will simply document what happens. There are no experimental drugs or special procedures required just for the study.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China
Sponsor
Zhengzhou Yuan
Enrollment target
~8,000 participants
Started
November 2023
Primary completion
December 2045
Last updated on clinicaltrials.gov in November 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhengzhou Yuan, MD
Department of Neurology, Affiliated Hospital of Southwest Medical University, LuZhou, China.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.